CVS to restore coverage of Zepbound, add Eli Lilly’s obesity pill to drug plans
RSS SUMMARY · AGGREGATED FROM CNBC
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Amazon engineers in Seattle slam employer for building AI data centers while laying off 30,000 staffers
CNBC·5h ago·3 min read
US
Elon Musk’s net worth poised to sail past $1 trillion in SpaceX IPO
CNBC·6h ago·3 min read
US
Broadcom stock slips on disappointing software revenue
CNBC·8h ago·3 min read
US
Senate GOP strips up to $1B for Trump ballroom security from immigration enforcement bill
CNBC·9h ago·3 min read
Related
On this beat
Business
Walmart’s $240 hybrid noise-canceling headphones are just $29 with 100 hours of playtime
THE STREET·28m ago·3 min read
Business
America’s ‘other’ economy tells a different growth story
FT·1h ago·3 min read
Business
Javier Milei: Argentina invites AI to free itself
FT·1h ago·3 min read
Business
Trump’s pledge to unleash a ‘golden age’ of US manufacturing sputters
FT·1h ago·3 min read